Xiangyi Kong, Ryan J Sullivan, Caisheng Wu, Lin Zhang, Lin Zhang, Lin Zhang, & Yu Jiang. (2022). Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXiangyi Kong, Ryan J Sullivan, Caisheng Wu, Lin Zhang, Lin Zhang, Lin Zhang, and Yu Jiang. Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationXiangyi Kong, et al. Editorial: Toxicity Mechanism and Clinical Features of PD-1/PD-L1 Inhibitors in Treatment of Cancer, Volume I. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.